Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives-Reference-Cited by-同舟云学术

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives

Published:2018-08-29 Issue:2 Volume:25 Page:403-409
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Bitton Alain¹,Vutcovici Maria¹,Lytvyak Ellina²,Kachan Natasha³,Bressler Brian⁴,Jones Jennifer⁵,Lakatos Peter L¹,Sewitch Maida¹,El-Matary Wael⁶,Melmed Gil⁷,Nguyen Geoffrey⁸, ,

Affiliation:

1. Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada

2. Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada

3. Crohn’s Colitis Canada

4. Department of Medicine, Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia, Canada

5. Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada

6. Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Canada

7. Division of Gastroenterology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA

8. Mount Sinai Hospital, Center for Inflammatory Bowel Disease, Department of Medicine, University of Toronto, Toronto, Canada

Funder

Crohn's and Colitis Canada

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/25/2/403/27470828/izy259.pdf

Reference24 articles.

1. Variation in care in pediatric crohn disease;Colletti;J Pediatr Gastroenterol Nutr,2009

2. Differences in the management of Crohn’s disease among experts and community providers, based on a national survey of sample case vignettes;Esrailian;Aliment Pharmacol Ther,2007

3. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists;Spiegel;Clin Gastroenterol Hepatol,2009

4. Variation in care of inflammatory bowel diseases patients in Crohn’s and Colitis Foundation of America Partners: role of gastroenterologist practice setting in disease outcomes and quality process measures;Weaver;Inflamm Bowel Dis,2016

5. Delphi consensus statement: quality indicators for inflammatory bowel disease comprehensive care units;Calvet;J Crohns Colitis,2014

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a set of measurable outcome indicators for Flemish patients with inflammatory bowel disease;European Journal of Gastroenterology & Hepatology;2024-06-19

2. Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial;Inflammatory Bowel Diseases;2024-03-20

3. Savings in social expenditures for work incapacity in patients with inflammatory bowel disease depend on access to innovative therapies in Poland;European Journal of Gastroenterology & Hepatology;2024-03-19

4. The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care;Journal of the Canadian Association of Gastroenterology;2023-09-01

5. Establishing key performance indicators for inflammatory bowel disease in the UK;Frontline Gastroenterology;2023-05-25